News Conference News ACC 2026 Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF L.A. McKeown April 08, 2026
News Conference News ACC 2026 SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF Todd Neale March 29, 2026
News Conference News THT 2026 Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data Todd Neale March 05, 2026
News Features Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts Michael O'Riordan February 24, 2026
News Daily News Even With Optimized GDMT, HFrEF Prognosis Remains Dire Michael O'Riordan January 30, 2026
News Daily News Cardioprotective Flush, Without Reanimation, Safe and Effective in DCD Transplant Michael O'Riordan January 28, 2026
News Daily News Telemedicine May Adversely Impact Care Quality for HF Patients Caitlin E. Cox January 26, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Conference News AHA 2025 POLY-HF: Polypill Pays Dividends in Patients With HFrEF Todd Neale November 14, 2025
News Daily News Getting Ready for a Heart Failure Polypill, Well Before the Data Are In Todd Neale October 16, 2025
News Daily News After Acute HF Admission, Specialist Care Tied to Better Long-term Outcomes Todd Neale October 07, 2025
News Daily News Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients Todd Neale September 12, 2025
News Conference News ESC 2025 PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy Michael O'Riordan September 01, 2025
News Conference News ESC 2025 Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR Michael O'Riordan August 31, 2025
Presentation ESC 2025 Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial Presenter: Faiez Zannad August 30, 2025
News Conference News ESC 2025 Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF Michael O'Riordan August 30, 2025
News Conference News ESC 2025 Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF Michael O'Riordan August 29, 2025